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and Central of review and dissemination (CRD databases) from 1966–June 2009. 
Keywords included macular degeneration with preference or utility or names of all 
possible techniques/tools used to derive utility or other synonyms. Original articles 
reporting health state utilities of patients with AMD were included. All articles were 
reviewed and extracted independently by two investigators for study design, popula-
tion and outcomes. Meta-analyses were performed using DerSimonian and Laird 
method under a random-effects model. RESULTS: Out of 1887 studies identiﬁ ed, 24 
studies met inclusion criteria. Twenty-one studies obtained utility directly from 
patients, while the others inquired ophthalmologists or community members to esti-
mate utility. Standard Gamble (SG) and time-trade off (TTO) were the most commonly 
techniques used in these studies (11 studies used TTO, while 5 studies used SG). Based 
on a meta-analysis of three studies which obtained utility from 510 patients and 
provided sufﬁ cient data for calculation, the utility values with 95% conﬁ dence inter-
vals for visual acuity of 20/20–20/25, 20/30–20/50, 20/60–20/100, 20/200–20/400 
and <20/400 were 0.91 (0.88–0.94), 0.81 (0.78–0.84), 0.68 (0.58–0.77), 0.62 (0.55–
0.68), and 0.46 (0.33–0.59) respectively. CONCLUSIONS: Our ﬁ ndings provided the 
pooled estimates of utilities for AMD patients for all visual acuity levels. It was found 
that the better visual acuity, the higher utility value. Researchers may use our pooled 
utilities as input parameters in their cost-effectiveness modeling studies. 
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OBJECTIVES: Psoriasis has a major impact on patients’ quality of life, as commonly 
measured by the Dermatology Life Quality Index (DLQI). This study has two objec-
tives: 1) to measure health-related utilities for patients with psoriasis and to measure 
the willingness-to-pay (WTP) for a cure for psoriasis, and 2) to examine how these 
different measures of utilities and WTP were related to DLQI. METHODS: Face-to-
face patient interviews were carried out with 364 patients with psoriasis during August 
2009 and February 2010 at dermatology outpatient clinics in ﬁ ve hospitals located in 
northern, central and southern Taiwan. Utilities were elicited using time trade-off 
(TTO), visual analogue scale (VAS) and EQ-5D. The EQ-5D was scored based on the 
standard scoring formula. The WTP for a cure of psoriasis was elicited by double 
bounded binary-choice questions followed by a bidding game question. RESULTS: 
Mean age was 44.5 years, mean history of disease was 11.2 years, and 77% of patients 
were male. The mean health utility was 0.87 (EQ-5D), 0.72 (VAS) and 0.75 (TTO). 
The WTP per month was between NT$7770.72 and NT$9411.50. Scores of EQ-5D 
and VAS were signiﬁ cantly negatively correlated to all of the dimensions of DLQI. 
The correlation of the dichotomous WTP with DLQI was also strong and in the 
expected direction. TTO was also signiﬁ cantly correlated with DLQI, but the relation 
was the weakest. CONCLUSIONS: EQ-5D, VAS and WTP are consistent measures 
with DLQI in assessing the well-being of patients with psoriasis in Taiwan. 
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OBJECTIVES: The impact of choice of pharmacotherapy for psoriasis on costs and 
patient outcomes in large nationally representative data in the United States needs 
further examination. This study examined the impacts of patient demographics and 
medication choices on patient’s health status and associated medication costs in the 
United States. METHODS: A retrospective cross-sectional study was conducted using 
the 2007 Medical Expenditure Panel Survey (MEPS) database. Information on patient 
demographics, health status, medication utilization, and medication costs were 
obtained from the database representing 605,089 patients with psoriasis. Weighted 
multiple linear regressions were used to examine the impacts of patient demographics 
and medication choices on patient’s health status and associated medication costs. 
RESULTS: Weighted multiple linear regression analyses indicated that the use of 
topical corticosteroids yielded 23.0% lower annual medication costs (compared to 
nonusers in logarithm format; P = 0.00), whereas the use of biological/systemic agents 
yielded 41.8% higher annual medication costs (compared to nonusers in logarithm 
format; P = 0.00). The study population using topical corticosteroids had 35.0% 
improvement in SF-12 PCS scores (compared to nonusers; P = 0.00), whereas patients 
using biological/systemic agents had 8.2% improvement in SF-12 PCS scores (com-
pared to nonusers; P = 0.00. ) The use of biological agents was elevated compared to 
previous studies. CONCLUSIONS: We observed an association with medication 
choice for psoriasis treatment on associated patient health status and medication 
spending in the United States. The retrospective nature of the study precludes assess-
ment of causality, but encouraging use of topical treatments may be an effective means 
to reduce psoriasis management costs. 
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OBJECTIVES: The objective of this study is to identify an existing instrument which 
could measure the health related quality of life of myopia patients receiving refractive 
surgery such as LASIK for group-level and individual-level decision-making. 
METHODS: Seven instruments were identiﬁ ed through a comprehensive literature 
search. Based on the criteria deﬁ ned by Scientiﬁ c Advisory committee of the Medical 
Outcome Trust (2002), selected instruments were evaluated using 12 criteria related 
to conceptual model, reliability (internal consistency and test-retest), validity(content 
validity and construct validity), responsiveness(cross-sectional and longitudinal), 
interpretability(availability of norms and quality of norms), burden(respondent and 
administrator), and depth. RESULTS: For the seven identiﬁ ed instruments, two were 
excluded because language criteria and one was excluded because it measured satisfac-
tion, not HRQOL. The remaining four instruments included National Eye Institute 
Refractive Error Quality of Life (NEI-RQL), Refractive Status and Vision Proﬁ le 
(RSVP), Quality of Life Impact of Refractive Correction (QIRC), Quality-of-life Scale 
for Myopia (QOLM). For 12 individual decision-making criteria, NEI-RQL, RSVP, 
QIRC and QOLM met 7, 7, 6, 5 criteria, respectively. For 12 group-level decision-
making criteria, NEI-RQL, RSVP, QIRC and QOLM met 9, 7, 8, 7 criteria, respec-
tively. CONCLUSIONS: Existing instruments do not fully meet the evaluation criteria. 
Most instruments lacked information or had problems with reliability (individual-level 
decision-making), longitudinal responsiveness, administrator burden, and depth. This 
study results showed that NEI-RQL met the most of the criteria. 
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OBJECTIVES: The NEI-RQL-42 developed by RAND Corporation in US English is 
a reliable, valid, and sensitive 42-item measure of the impact of refractive status on 
patients’ day-to-day life. No Simpliﬁ ed Chinese or Hindi versions existed previously. 
For an international study, the NEI-RQL-42 had to be translated and linguistically 
validated in Simpliﬁ ed Chinese for China and Hindi for India. METHODS: A stan-
dardized linguistic validation methodology was conducted by specialists for each 
target country: 1) concept deﬁ nition; 2) dual forward translations by independent 
native-speaking linguists; 3) reconcili-ation of the forward translations; 4) back trans-
lation into English by a native speaking linguist; 5) resolution of the back translation; 
6) international harmonization; 7) clinician (Ophthalmologist) review; 8) cognitive 
debrieﬁ ng comprehension interviews on ﬁ ve Mandarin/Simpliﬁ ed Chinese and ﬁ ve 
Hindi native-speaking patients who are either pre- or post-cataract surgery; and 9) 
ﬁ nal proofreading. RESULTS: The main challenge on the conceptual level was the 
English original made extensive use of driving scenarios during the day and night in 
the US English source instrument to elicit responses. For Hindi and Simpliﬁ ed Chinese, 
driving scenarios were supplemented with walking and cycling, which were more 
relevant in the local context without compromising the conceptual intent of the source 
instrument. On the linguistic level, translating some of the frequency terms required 
discussion with the developer to identify a solution, as the gradation between the 
surrounding English response options was difﬁ cult to exactly match on a conceptual 
level in the target language due to linguistic limitations. CONCLUSIONS: According 
to the rigorous methodology used, with some minor adjustments, the Mandarin and 
Hindi versions of the NEI-RQl-42 were qualitatively conceptually equivalent and 
culturally relevant. The Simpliﬁ ed Chinese and Hindi versions were successfully lin-
guistically validated to measurement of the impact of refractive error on patients’ 
day-to-day lives and facilitate the comparison and pooling of data. 
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OBJECTIVES: Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis 
(TEN), caused by allopurinol therapy, are strongly associated with the human leuko-
cyte antigen (HLA), HLA-B*5801. It was unclear at what price the genetic testing 
would be a cost-effective strategy compared to no testing. This study aims to determine 
the range of genotyping cost that would be cost-effective from health-care provider 
perspective. METHODS: A decision analytic model was used to estimate the cost-
